Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

Memorial Sloan Kettering Cancer Center, University College Hospital, University College London, Asan Medical Center, University of Ulsan, Gentofte Hospital, Region of Southern Denmark, University of Amsterdam, Utrecht University, University Medical Center Utrecht, Amsterdam University Medical Centers, Bordeaux Population Health, Hospital Universitario 12 De Octubre, Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Western Health, Centre Léon Bérard, Instituto de Investigación Marqués de Valdecilla, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Sidney Kimmel Comprehensive Cancer Center, National Cancer Center Hospital East, Merck & Co., Inc., Rahway, NJ, USA (United States), Sorbonne Université, Centre de Recherche Saint-Antoine, Inserm